Li X - Search Results

1

Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a via Targeting the NF-κB Signaling Pathway.

Wang H, Zhang Y, Wu X, Wang Y, Cui H, Li X, Zhang J, Tun N, Peng Y, Yu J. Wang H, et al. Among authors: li x. Front Immunol. 2018 Mar 9;9:293. doi: 10.3389/fimmu.2018.00293. eCollection 2018. Front Immunol. 2018. PMID: 29593706 Free PMC article.

2

The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells.

Li X, Dong W, Nalin AP, Wang Y, Pan P, Xu B, Zhang Y, Tun S, Zhang J, Wang LS, He X, Caligiuri MA, Yu J. Li X, et al. Oncoimmunology. 2018 Mar 13;7(6):e1431085. doi: 10.1080/2162402X.2018.1431085. eCollection 2018. Oncoimmunology. 2018. PMID: 29872557 Free PMC article.

3

Targeting the RNA m⁶A modification for cancer immunotherapy.

Li X, Ma S, Deng Y, Yi P, Yu J. Li X, et al. Mol Cancer. 2022 Mar 16;21(1):76. doi: 10.1186/s12943-022-01558-0. Mol Cancer. 2022. PMID: 35296338 Free PMC article. Review.

4

miR-582 Suppresses the Proliferation of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells and Protects Them From Natural Killer Cell-Mediated Cytotoxicity.

Li X, Zhang Y, He F, Gao D, Che B, Cao X, Huang S, Zheng M, Han H. Li X, et al. Front Immunol. 2022 Apr 20;13:853094. doi: 10.3389/fimmu.2022.853094. eCollection 2022. Front Immunol. 2022. PMID: 35514986 Free PMC article.

5

The Notch signaling pathway: a potential target for cancer immunotherapy.

Li X, Yan X, Wang Y, Kaur B, Han H, Yu J. Li X, et al. J Hematol Oncol. 2023 May 2;16(1):45. doi: 10.1186/s13045-023-01439-z. J Hematol Oncol. 2023. PMID: 37131214 Free PMC article. Review.

6

Cancer immunotherapy and its facilitation by nanomedicine.

Sui C, Wu H, Li X, Wang Y, Wei J, Yu J, Wu X. Sui C, et al. Among authors: li x. Biomark Res. 2024 Aug 3;12(1):77. doi: 10.1186/s40364-024-00625-6. Biomark Res. 2024. PMID: 39097732 Free PMC article. Review.

7

SMAD4 enhances the cytotoxic efficacy of human NK cells against colorectal cancer cells via the m⁶A reader YTHDF2.

Li X, Wang Y, Cai L, Huang S. Li X, et al. Front Immunol. 2024 Oct 7;15:1440308. doi: 10.3389/fimmu.2024.1440308. eCollection 2024. Front Immunol. 2024. PMID: 39439794 Free PMC article.

8

SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM‑1 via the PTEN/PI3K/AKT signaling pathway in vitro and in vivo.

Yin J, Li X, Zhang Z, Luo X, Wang L, Liu L. Yin J, et al. Among authors: li x. Int J Oncol. 2018 Jul;53(1):297-306. doi: 10.3892/ijo.2018.4390. Epub 2018 May 2. Int J Oncol. 2018. PMID: 29749435

9

SPAG6 regulates cell apoptosis through the TRAIL signal pathway in myelodysplastic syndromes.

Li X, Yang B, Wang L, Chen L, Luo X, Liu L. Li X, et al. Oncol Rep. 2017 May;37(5):2839-2846. doi: 10.3892/or.2017.5540. Epub 2017 Mar 31. Oncol Rep. 2017. PMID: 28393201

10

Sweroside Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress and Pyroptosis Partially via Modulation of the Keap1/Nrf2 Axis.

Li J, Zhao C, Zhu Q, Wang Y, Li G, Li X, Li Y, Wu N, Ma C. Li J, et al. Among authors: li y, li g, li x. Front Cardiovasc Med. 2021 Mar 19;8:650368. doi: 10.3389/fcvm.2021.650368. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33816579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184,248 results

Search Page

Filters